The aim of this study was to determine concordance between physician and patient blood pressure (BP) measurements in an ambulatory setting. A diagnostic intervention cross-sectional study using a convenience sample was employed. A total of 106 hypertensive patients were included in the study. Patients who were unable to perform their self-measurement or those with cardiac arrhythmia were excluded. BP was determined nine times in each subject in the medical office in a randomised order: BP was taken three times by the physician using a mercury sphygmomanometer (SPHHg), three times by the physician using a validated, automated oscillometer (Omron HEM 705 CP), and three times by the patient himself with the same device. The intraclass correlation coefficient was calculated. In all, 59 women and 47 men aged 65.7 (10) years were analysed. Mean BP measurements for the physician using the mercury sphygmomanometer, the physician using the Omron, and the patient using the same device were: 136 (15.8)/80 (11), 137 (17.9)/80 (10), and 139* (17.6)/80 (10) mmHg, respectively. BP control was 48.1, 48.1, and 36.8*% (*Po0.05), respectively. Intraclass correlation coefficients for systolic/diastolic pressures were: 0.77/0.65 (physicianFsphygmomanometer Hg, physicianFOmron;
Introduction
The measurement of blood pressure (BP) is one of the most commonly performed tasks in an ambulatory primary care setting. However, it is not always easy to measure BP accurately under the required standardised basal conditions [1] [2] [3] because of logistic deficiencies (for instance, poorly calibrated systems or use of cuffs in obese subjects) or organisational deficiencies (for instance, high demand for healthcare services or inexistence of an area in the medical office specifically designed to measure BP). 4, 5 In view of these inadequate conditions, it becomes necessary to promote changes that will improve and facilitate the measurement of BP in an ambulatory setting, such as the introduction of validated automated BP measurement systems.
It is a known fact that BP readings vary, depending on where the measurement is taken. Thus, ambulatory BP is always lower than office BP [6] [7] [8] [9] [10] and lower than work self-measured BP. 11 However, these measurements may also vary, depending on the observer or healthcare professional: BP values obtained by the nursing staff are lower than those obtained by the physician. 12 Our study was conducted within this framework, with the aim of evaluating our working hypothesis, which is that office self-measurement of BP by the actual patient would not only expedite the consultations but would also yield BP values lower than those obtained by the physician, with better BP control. Given that we are not aware of the existence of any studies specifically designed to evaluate the concordance between office BP measurements performed by the patient vs office BP measurements performed by the physician, the purpose of this study was to assess the existence of such possible concordance, using a mercury sphygmomanometer and a validated automated system, in routine clinical practice.
Material and method
This is a diagnostic intervention cross-sectional study conducted between August and October 2000 in an urban primary care centre using a convenience sample. Hypertensive patients who were being treated in six GPs' ambulatory practices for hypertension or other medical conditions, and who had agreed to participate, were enrolled in the study. All patients were trained in the use of the validated automated oscillometer for BP measurement 13 with an accompanying printer (Omron HEM 705 CP). Those hypertensive patients who after being trained tried to self-measure their BP but whom, in the opinion of their GP, failed to use the automated system correctly, or for any other reason were unable to complete the self-measurements, were excluded. Patients with cardiac arrhythmia (by possible reading errors of the oscillometric devices) were also excluded. BP was randomly measured nine times in each patient under basal conditions in the medical office: three times by the physician using a calibrated mercury sphygmomanometer, three times by the physician with the Omron device, and three times by the patient also with the Omron device. All physician BP measurements were carried out by each of the patient's GP. The nursing staff did not participate in the BP measurement because this study examined the worst clinical situation possible: BP values obtained by the physician in the office are higher than those obtained by the nurse. 12 BP measurements were taken at 2 min intervals. Six different pads were designed for the collection of data, indicating all the possible BP measurement combinations (unrepeated combination of three measurements taken three at a time). These data collection pads were randomly distributed among the attending GPs of the six participating practices, thus varying the order in which the BP measurements were taken in each subject. The measurements could start either with the patient's self-measurement or with the physician's measurement using any of the two systems mentioned, and including all possible combinations. The arm cuff was left in place between readings, except when the measurement device had to be changed (from the Omron device to the mercury sphygmomanometer, or vice versa). A special cuff for obese patients was used when needed. All through the nine BP measurements, the patient remained seated in the medical office, with the arm in the same position. To perform the actual self-measurements, the patient was left alone in the office (the physician and the nurse left the room) and the phone was disconnected. The patient printed the self-measurement readings. BP control was defined when the BP values were below 140/ 90 mmHg (or below 130/85 mmHg for diabetic patients).
Statistical analysis
Measures of central tendency were calculated for quantitative variables, and frequency distributions for qualitative variables. For variables of normal distributions according to the Kolmogorov-Smirnov test, the existence of correlation between qualitative variables was evaluated using the w 2 tests or the Fisher exact test. For the analysis of quantitative variables, Student's t-test and the variance analysis test were used in all cases, considering Po0.05 as a significant value. Nonparametric tests were used when the variables were outside the normal distribution. For concordance analysis between BP measurements, the intraclass correlation coefficient and the McNemar test were used in order to evaluate the association between paired categorical variables. The Bland-Altman 14 test was used for determinations that employed the physician and patient electronic equipment, with the aim of evaluating the differences between both measurement methods. Good concordance was defined if the difference median between both measurement methods was equal to or below 5 mmHg, with a typical deviation equal to or below 8 mmHg for systolic blood pressure (SBP) and diastolic blood pressure (DBP). 15 
Results
Given that the group of patients was composed of a convenience sample under routine clinical practice conditions, we are unable to identify the number of patients who refused to participate in the study after being verbally told by their GP. However, 114 hypertensive subjects agreed to be included. Of these, eight had to be excluded because of their inability to use the automated measurement device properly after being trained on its use (they did not run the complete three self-measurements, did not print some of the readings, or did not allow at least 2 min between measurements, as indicated in the printout). In the end, 106 hypertensive subjects, 59 females and 47 males, with a mean age (s.d.) of 65.7 (10) years and a BP mean evolution of 108.7 months (range: 1-276) were included. According to the cardiovascular risk, 36 (34%) patients had grade C hypertension, 17 (16%) grade B hypertension, and 53 (50%) grade A 16 hypertension. In all, 55 (52%) were obese.
Concerning the treatment for hypertension, 13 (12.3%) did not receive any sort of antihypertensive drug therapy, 41 (38.7%) were taking one drug, 34 (32.1%) were taking two drugs, 15 (14.2%), were taking three drugs, and three (2.8%) were taking four drugs.
BP determinations as measured by the physician with the mercury sphygmomanometer, by the physician with the Omron device, and by the patient with the same device in the office, as well as the level of BP control, according to each measurement method, are shown in Table 1 . SBP was significantly
Office blood pressure self-measurement E Vinyoles et al higher when determined by the patient as compared to that of the physician using the mercury sphygmomanometer. BP control was significantly worse when the measurement was performed by the patient himself. When the first of the three patient self-measurements was eliminated, such differences disappeared (Table 2) . No significant differences were found in relation to the heart rate, as measured by the Omron device or by radial palpation by the physician. Table 3 shows the intraclass correlation index values between observers and measurement devices, all of which are Po0.001. Figure 1 shows the BlandAltman analysis for SBP and DBP between the Omron measurement as taken by the physician and as taken by the patient self-measurement, after the first of the three determinations taken by the patient was eliminated. The mean difference between both methods for SBP and DBP was 0.28 (10.09) and 0.16 (6.13) mmHg, respectively.
Discussion
Even though a significant or nearly perfect concordance 17 between physician and patient BP determinations is found, this study was unable to confirm our initial working hypothesis. That is to say, a tendency towards a worse BP control is found when it is the actual patient who performs the selfmeasurement in the office as a result of an elevated SBP. SBP shows greater variability than DBP, and it probably has greater sensitivity than DBP to detect alert reactions in the patient. Although in our study we tried to carry out the patient self-measurements in the most relaxing possible environment (with the patient alone and undisturbed), we were probably not that successful. The self-measurement 'scenario' was still an 'unusual' or 'out of the ordinary' situation for the patient, who probably felt nervous about the entire experience. However, when the first of the three consecutive readings was eliminated, no significant differences were found among the three different measurement methods, thereby ratifying our working hypothesis. The elimination of this first reading minimised the initial 'alert' or 'nervous' patient reaction associated with the first selfmeasurement (the period of time required to become familiarised with the automated equipment and feel more relaxed in the medical setting). In this sense, consensus has been reached by some authors to eliminate the first of the three BP determinations when the patient performs self BP measurements at home or, alternatively, all the readings on the first day. 18 A thorough review of the literature showed that virtually no studies exist that assess BP selfmeasurement in the medical setting. In one study, 19 whose primary objective was not to analyse the concordance between both measurements, BP selfmeasurement by the patient in the medical office did not vary significantly from that recorded by the physician, with a concordance similar to that found in our study. According to Myers et al, 19 the selfmeasurement of BP by the patient in the medical office does not diminish the magnitude of the 'white gown' effect. In our experience, an alarm reaction is even detected in the first self-measurement by the patient, with an increase of SBP. One of the limitations of our study is the fact that it is based on a convenience sample, which may have prompted a selection bias. Probably, physicians did not even think of including certain patients when they felt that these patients would find it difficult to learn how to use the selfmeasurement device. Our exclusion rate (7%) is good considering a fairly elderly population. Although the spread of patients in terms of grade of hypertension and number of medications received seems representative of primary care, the results cannot be extrapolated to the global hypertensive population treated, but only to those patients who were capable of performing the selfmeasurement correctly, even more so when we do not know the characteristics of the patients who did not make it to the preselection stage.
It is also of great interest to know that the readings obtained by the physician in the medical office using a validated automated device show good concordance with the readings obtained with the sphygmomanometer under routine clinical practice conditions. Owing to the toxicity of mercury, a minimal use in the environment 20 is proposed, as well as a progressive replacement of sphygmomano-meters by validated automated devices. 21 However, there is insufficient epidemiologic and prognostic information available on the use of these new devices in the medical practice. There is, though, information on their use in Office blood pressure self-measurement E Vinyoles et al ambulatory self-measurement. [22] [23] [24] According to the results of our study, at least in our centre, conventional BP measurement by means of sphygmomanometers can be safely replaced by automated validated devices. In our experience, these devices not only ensure the accuracy and standardisation of BP readings in the medical office, but also expedite and improve the reliability of BP determinations in situations of high healthcare demand. The patient remains seated and, in addition, several BP readings and heart rates are easily obtained, bringing the observer's biases to a minimum.
In summary, this study provides two important aspects in relation to the measurement of BP: (1) BP can be determined in the medical practice by means of an automated desktop device or mercury sphygmomanometer, indistinctly, under routine clinical practice conditions, and (2) BP self-measurement in the medical office setting by the patient tends to overestimate SBP and, thus, worsen BP control. Eliminating the first of the three patient self-measurements improves SBP concordance. Nonetheless, according to the Bland-Altman analysis, this does not appear to suffice to affirm that SBP determination by the physician and by the patient may be interexchangeable from the clinical point of view. In contrast, there is in fact an excellent concordance for DBP. With the design of our study, it is not possible for us to determine which hypertensive patients present a greater SBP variability and, consequently, worse concordance between both measurement methods.
In the light of these results, the future replacement of mercury sphygmomanometers by validated automated devices will not significantly impinge on BP measurement values, at least in our experience. In our centre, we are also looking into the possibility of allocating a special room where the patient can perform the self-measurement, which will optimise and improve the quality time we dedicate to our patients. Moreover, self-measurement in the medical office can result in other advantages for the patient such as hypothetical improvement in therapeutic compliance. However, further studies are needed, with a larger number of subjects, which would enable the analysis of subsets or subgroups in order to detect predictor variables of good concordance for SBP.
